Your browser doesn't support javascript.
loading
Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Ustekinumab and BAT2206 in Healthy Chinese Male Subjects in a Double-Blind, Randomized, Single-Dose, Parallel-Group Phase I Trial.
Wu, Min; Li, Xiaojiao; Yang, Deming; Wang, Meng; Zhang, Hong; Li, Cuiyun; Mai, Jiajia; Yang, Lizhi; Qi, Yunpeng; Yu, Jin-Chen; Yang, Xiaolei; Wang, Zhaohe; Gu, Cailing; Ding, Yanhua.
Affiliation
  • Wu M; Phase I Clinical Research Center, First Hospital of Jilin University, No. 1, Xinmin Street, Changchun, Jilin, China.
  • Li X; Phase I Clinical Research Center, First Hospital of Jilin University, No. 1, Xinmin Street, Changchun, Jilin, China.
  • Yang D; Phase I Clinical Research Center, First Hospital of Jilin University, No. 1, Xinmin Street, Changchun, Jilin, China.
  • Wang M; Phase I Clinical Research Center, First Hospital of Jilin University, No. 1, Xinmin Street, Changchun, Jilin, China.
  • Zhang H; Phase I Clinical Research Center, First Hospital of Jilin University, No. 1, Xinmin Street, Changchun, Jilin, China.
  • Li C; Phase I Clinical Research Center, First Hospital of Jilin University, No. 1, Xinmin Street, Changchun, Jilin, China.
  • Mai J; Phase I Clinical Research Center, First Hospital of Jilin University, No. 1, Xinmin Street, Changchun, Jilin, China.
  • Yang L; Nanguan District Maternal and Child Health and Family Planning Service Center of Changchun, Changchun, Jilin, China.
  • Qi Y; Bio-Thera Solutions, Ltd., Guangzhou, Guangdong, China.
  • Yu JC; Bio-Thera Solutions, Ltd., Guangzhou, Guangdong, China.
  • Yang X; Bio-Thera Solutions, Ltd., Guangzhou, Guangdong, China.
  • Wang Z; Bio-Thera Solutions, Ltd., Guangzhou, Guangdong, China.
  • Gu C; Bio-Thera Solutions, Ltd., Guangzhou, Guangdong, China.
  • Ding Y; Phase I Clinical Research Center, First Hospital of Jilin University, No. 1, Xinmin Street, Changchun, Jilin, China. dingyanh@jlu.edu.cn.
BioDrugs ; 37(1): 89-98, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36417156

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals / Ustekinumab / East Asian People Type of study: Clinical_trials Limits: Humans / Male Language: En Journal: BioDrugs Journal subject: ALERGIA E IMUNOLOGIA / GENETICA MEDICA / TERAPEUTICA / TERAPIA POR MEDICAMENTOS Year: 2023 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals / Ustekinumab / East Asian People Type of study: Clinical_trials Limits: Humans / Male Language: En Journal: BioDrugs Journal subject: ALERGIA E IMUNOLOGIA / GENETICA MEDICA / TERAPEUTICA / TERAPIA POR MEDICAMENTOS Year: 2023 Type: Article Affiliation country: China